← Main Index Directory
Tesamorelin Assay Protocol
In-Vitro ArchitectureDelivery & Half-Life Parameters
Validated Mapping Vector: Strictly subcutaneous injection formats. Must be kept at low temperatures.
Biological Half-Life Metric: Highly stable configuration yielding an active biological window of ~38 minutes.
Recommended In-Vitro Dosing Architecture
Rigid dosing requirement: 1mg to 2mg administered subcutaneously 5 days per week. Must be deployed during a fasted state before bed.
Standard Target Observation Timelines
Evaluated over extended 12 to 24-week intervals to accurately trace reductions in deep visceral fat layers.